Tumor-immune profiling of CT-26 and Colon 26 syngeneic mouse models reveals mechanism of anti-PD-1 response

被引：0
|
作者：
Yosuke Sato
Yu Fu
Hong Liu
Min Young Lee
Michael H. Shaw
机构：
[1] Immuno-oncology Drug Discovery Unit,
[2] Millennium Pharmaceuticals,undefined
[3] Inc. a wholly owned subsidiary of Takeda Pharmaceutical Company Limited,undefined
[4] Guardant Health,undefined
[5] Checkmate Pharmaceuticals,undefined
来源：
BMC Cancer | / 21卷
关键词：
Immune checkpoint blockade; Anti-PD-1; Syngeneic model; CT-26; Colon 26; Anti-tumor activity; Wnt;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] IL-12-gene expression by CT26 colon carcinoma cells induces an anti-tumor immune memory effective in the rejection or syngeneic mammary tumor cells
    Adris, S
    Bravo, A
    Klein, S
    Jasnis, M
    Carbone, C
    Chernajovsky, Y
    Podhajcer, O
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) : 363 - 363
  • [42] Chidamide plus Tyrosine Kinase Inhibitor Remodel the Tumor Immune Microenvironment and Reduce Tumor Progression When Combined with Immune Checkpoint Inhibitor in Naive and Anti-PD-1 Resistant CT26-Bearing Mice
    Chen, Jia-Shiong
    Hsieh, Yi-Chien
    Chou, Cheng-Han
    Wu, Yi-Hong
    Yang, Mu-Hsuan
    Chu, Sz-Hao
    Chao, Ye-Su
    Chen, Chia-Nan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (18)
  • [43] GM-CSF augmented the photothermal immunotherapeutic outcome of self-driving gold nanoparticles against a mouse CT-26 colon tumor model
    Jie Dai
    Jianmei Li
    Yuqin Zhang
    Qian Wen
    Yun Lu
    Yu Fan
    Fancai Zeng
    Zhiyong Qian
    Yan Zhang
    Shaozhi Fu
    Biomaterials Research, 27
  • [44] GM-CSF augmented the photothermal immunotherapeutic outcome of self-driving gold nanoparticles against a mouse CT-26 colon tumor model
    Dai, Jie
    Li, Jianmei
    Zhang, Yuqin
    Wen, Qian
    Lu, Yun
    Fan, Yu
    Zeng, Fancai
    Qian, Zhiyong
    Zhang, Yan
    Fu, Shaozhi
    BIOMATERIALS RESEARCH, 2023, 27 (01)
  • [45] AAV Mediated Expression of Mouse IL-12 Shows Potent Anti-Tumor Activity and Immune Response Alone and in Combination with Anti-PD1 in Syngeneic Murine Tumor Models
    Sutton, David
    Prentiss, Pilar
    Furmanski, Brian
    MOLECULAR THERAPY, 2022, 30 (04) : 161 - 161
  • [46] Remodeling the tumor-immune microenvironment by anti-CTLA4 blockade enhanced subsequent anti-PD-1 efficacy in advanced nasopharyngeal carcinoma
    Yuxiang Ma
    Huaqiang Zhou
    Fan Luo
    Yang Zhang
    Changbin Zhu
    Weiwei Li
    Zhan Huang
    Jingbo Zhao
    Jinhui Xue
    Yuanyuan Zhao
    Wenfeng Fang
    Yunpeng Yang
    Yan Huang
    Li Zhang
    Hongyun Zhao
    npj Precision Oncology, 8
  • [47] Remodeling the tumor-immune microenvironment by anti-CTLA4 blockade enhanced subsequent anti-PD-1 efficacy in advanced nasopharyngeal carcinoma
    Ma, Yuxiang
    Zhou, Huaqiang
    Luo, Fan
    Zhang, Yang
    Zhu, Changbin
    Li, Weiwei
    Huang, Zhan
    Zhao, Jingbo
    Xue, Jinhui
    Zhao, Yuanyuan
    Fang, Wenfeng
    Yang, Yunpeng
    Huang, Yan
    Zhang, Li
    Zhao, Hongyun
    NPJ PRECISION ONCOLOGY, 2024, 8 (01)
  • [48] Peripheral blood immune profiling of anti-PD-1 therapy in human melanoma reveals a link between T cell re-invigoration and tumor burden that predicts response
    Huang, Alexander
    Postow, Michael A.
    Orlowski, Robert J.
    Mick, Rosemarie
    Bengsch, Bertram
    Manne, Sasi
    Xu, Wei
    Harmon, Shannon
    Adamow, Matthew
    Kuk, Deborah
    Panangeas, Katherine
    Carerra, Cristina
    Wong, Phillip
    Quagliarello, Felix
    Pauken, Kristen E.
    Herati, Ramin S.
    McGettigan, Suzanne
    Kothari, Shawn
    George, Sangeeth M.
    Wenz, Brandon
    D'Andrea, Kurt
    Xu, Xiaowei
    Amaravadi, Ravi K.
    Karakousis, Giorgos
    Schuchter, Lynn M.
    Nathanson, Katherine L.
    Wolchok, Jedd D.
    Gangadhar, Tara C.
    Wherry, John
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [49] Influence of tumor mutation burden on response to anti-PD-1 treatment in murine models of melanoma
    Galvani, Elena
    Hogan, Kate
    Gremel, Gabriela
    Viros, Amaya
    Mandal, Amit K.
    Smith, Matthew
    Swan, Jacqueline
    Banyard, Antonia
    Ashton, Garry
    Dhomen, Nathalie
    Marais, Richard
    CANCER RESEARCH, 2016, 76
  • [50] Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy
    Taube, J. M.
    Klein, A.
    Brahmer, J. R.
    Xu, H.
    Pan, X.
    Kim, J.
    Chen, L.
    Pardoll, D. M.
    Topalian, S. L.
    Anders, R. A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 : S92 - S92
12345